Research
Genetic and phenotypic plasticity of cancer : Ch. Theillet/C. Sardet

Pomel C, Lecuru F, Leblanc E, Mathevet P, Colombo P-E, Collinet P, Nadeau C, Huchon C, Chereau E, Lambaudie E, Ferry P, Rafii A, Rouzier R [Minimal invasive surgery for early stage cervical cancer. Recommendations from the GINECO surgeon's group]. Bull Cancer. Jul 25, 2019. doi:10.1016/j.bulcan.2019.05.010

Bakrin N, Classe J, Colombo P, Ferron G, Freyer G, Glehen O, Gouy S, Huchon C, Narducci F, Pocard M, Pomel C, Rouzier R [CHIP and ovarian cancer]. Gynecol Obstet Fertil Senol. Jun 26, 2019. doi:10.1016/j.gofs.2019.06.007

Roux P, Knight S, Cohen M, Classe J, Mazouni C, Chauvet M-P, Reyal F, Colombo P-E, Jouve E, Chopin N, Daraï E, Coutant C, Lambaudie E, Houvenaeghel G Tubular and mucinous breast cancer: results of a cohort of 917 patients. 2019;105(1):55-62. doi:10.1177/0300891618811282

von Minckwitz G, Huang C-S, Mano M, Loibl S, Mamounas E, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer H, Jacot W, Conlin A, Arce-Salinas C, Wapnir I, Jackisch C, DiGiovanna M, Fasching P, Crown J, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam L, Tesarowski D, Smitt M, Douthwaite H, Singel S, Geyer C Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. N. Engl. J. Med.. 2019;380(7):617-628. doi:10.1056/NEJMoa1814017

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, Firmin N, Guiu S, Jacot W, Lehmann S The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases. BMC Cancer. 2019;19(1):110. doi:10.1186/s12885-019-5287-z

Chartron E, Theillet C, Guiu S, Jacot W Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data. Crit. Rev. Oncol. Hematol.. 2019;133. doi:10.1016/j.critrevonc.2018.10.012

Carayol M, Ninot G, Senesse P, Bleuse J-P, Gourgou S, Sancho-Garnier H, Sari C, Romieu I, Romieu G, Jacot W Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial. BMC Cancer. 2019;19(1):737. doi:10.1186/s12885-019-5896-6

Carrier G, Rouanet P, Colombo P Robotic colon resection for splenic flexure cancer with intracorporeal anastomosis (with video). J Visc Surg. Jul 16, 2019. doi:10.1016/j.jviscsurg.2019.06.013

Jacot W, Heudel P-E, Fraisse J, Gourgou S, Guiu S, Dalenc F, Pistilli B, Campone M, Levy C, Debled M, Leheurteur M, Chaix M, Lefeuvre C, Goncalves A, Uwer L, Ferrero J-M, Eymard J-C, Petit T, Mouret-Reynier M-A, Courtinard C, Cottu P, Robain M, Mailliez A Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. Int. J. Cancer. May 14, 2019. doi:10.1002/ijc.32402

Cabel L, Carton M, Cheaib B, Pierga J-Y, Dalenc F, Mailliez A, Levy C, Jacot W, Debled M, Leheurteur M, Desmoulins I, Lefeuvre C, Uwer L, Ferrero J-M, Eymard J-C, Petit T, Mouret-Reynier M-A, Perrocheau G, Piot I, Pérol D, Simon G, Lerebours F Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens. Breast Cancer Res. Treat.. 2019;173(2):397-406. doi:10.1007/s10549-018-5017-2

Houvenaeghel G, de Nonneville A, Cohen M, Classe J-M, Reyal F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo P-E, Gimbergues P, Chauvet M-P, Azuar A-S, Rouzier R, de Lara C, Muracciole X, Agostini A, Lambaudie E Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact. Breast Cancer Res. Treat.. 2019;173(1):111-122. doi:10.1007/s10549-018-4944-2

Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz L, Roger P, Guiu S, Derocq D, Robin G, Michaud H-A, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget J-P, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. J Immunother Cancer. 2019;7(1):29. doi:10.1186/s40425-019-0498-z

Puszkiel A, Arellano C, Vachoux C, Evrard A, Le Morvan V, Boyer J-C, Robert J, Delmas C, Dalenc F, Debled M, Venat-Bouvet L, Jacot W, Suc E, Sillet-Bach I, Filleron T, Roché H, Chatelut E, White-Koning M, Thomas F Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study. Clin. Pharmacol. Ther.. Feb 20, 2019. doi:10.1002/cpt.1404

Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin J, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E ERR? promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors. Oncogene. 2019;38(7):950-964. doi:10.1038/s41388-018-0579-3

Fonti C, Saumet A, Abi-Khalil A, Orsetti B, Cleroux E, Bender A, Dumas M, Schmitt E, Colinge J, Jacot W, Weber M, Sardet C, du Manoir S, Theillet C Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells. Int. J. Cancer. 2019;145(5):1299-1311. doi:10.1002/ijc.32413

Paul C, Delpech H, Haouzi D, Hamamah S, Sardet C, Fabbrizio E Coprs inactivation leads to a derepression of LINE1 transposons in spermatocytes. FEBS Open Bio. 2019;9(1):159-168. doi:10.1002/2211-5463.12562

Scholl S, Popovic M, de la Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M, Samuels S, Zijlmans H, Kenter G, Hillemanns P, Dema S, Dema A, Malenkovic G, Djuran B, Floquet A, Garbay D, Guyon F, Colombo P, Fabbro M, Kerr C, Ngo C, Lecuru F, Campo E, Coutant C, Marchal F, Mesgouez-Nebout N, Fourchotte V, Feron J, Morice P, Deutsch E, Wimberger P, Classe J-M, Gleeson N, von der Leyen H, Minsat M, Dubot C, Gestraud P, Kereszt A, Nagy I, Balint B, Berns E, Jordanova E, Saint-Jorre N, Savignoni A, Servant N, Hupe P, de Koning L, Fumoleau P, Rouzier R, Kamal M Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome. EBioMedicine. Apr 02, 2019. doi:10.1016/j.ebiom.2019.03.069

Bourillon L, Bourgier C, Gaborit N, Garambois V, Llès E, Zampieri A, Ogier C, Jarlier M, Radosevic-Robin N, Orsetti B, Delpech H, Theillet C, Colombo P-E, Azria D, Pèlegrin A, Larbouret C, Chardès T An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. Int. J. Cancer. Mar 18, 2019. doi:10.1002/ijc.32273

de Nonneville A, Jauffret C, Classe J-M, Cohen M, Reyal F, Mazouni C, Chauvet M-P, Chopin N, Colombo P-E, Jouve E, Rouzier R, Coutant C, Gimbergues P, Azuar A-S, de Lara C, Lambaudie E, Houvenaeghel G Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit. Breast Cancer Res. Treat.. 2019;175(2):379-387. doi:10.1007/s10549-019-05160-9

Gobbini E, Ezzalfani M, Dieras V, Bachelot T, Brain E, Debled M, Jacot W, Mouret-Reynier M, Goncalves A, Dalenc F, Patsouris A, Ferrero J, Levy C, Lorgis V, Vanlemmens L, Lefeuvre-Plesse C, Mathoulin-Pelissier S, Petit T, Uwer L, Jouannaud C, Leheurteur M, Lacroix-Triki M, Cleaud A, Robain M, Courtinard C, Cailliot C, Delaloge S Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. Eur. J. Cancer. 2018;96. doi:10.1016/j.ejca.2018.03.015

Ogier C, Colombo P-E, Bousquet C, Canterel-Thouennon L, Sicard P, Garambois V, Thomas G, Gaborit N, Jarlier M, Pirot N, Pugnière M, Vie N, Gongora C, Martineau P, Robert B, Pèlegrin A, Chardès T, Larbouret C Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Lett.. 2018;432. doi:10.1016/j.canlet.2018.06.023

Idoux-Gillet Y, Nassour M, Lakis E, Bonini F, Theillet C, Savagner P Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma. Oncogene. 2018;37(5):578-588. doi:10.1038/onc.2017.355

Chiba A, Raman R, Thomas A, Lamy P-J, Viala M, Pouderoux S, Mott S, Schroeder M, Thezenas S, Jacot W Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer. Clin. Breast Cancer. 2018;18(2):144-149. doi:10.1016/j.clbc.2017.12.001

Rouanet P, Bertrand M, Jarlier M, Mourregot A, Traore D, Taoum C, de Forges H, Colombo P-E Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives. Ann. Surg. Oncol.. 2018;25(12):3572-3579. doi:10.1245/s10434-018-6738-5

Martinez A, Filleron T, Rouanet P, Méeus P, Lambaudie E, Classe J, Foucher F, Narducci F, Gouy S, Guyon F, Marchal F, Jouve E, Colombo P, Mourregot A, Rivoire M, Chopin N, Houvenaeghel G, Jaffre I, Leveque J, Lavoue V, Leblanc E, Morice P, Stoeckle E, Verheaghe J, Querleu D, Ferron G Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study. Ann. Surg. Oncol.. 2018;25(2):535-541. doi:10.1245/s10434-017-6120-z



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés